+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Colistimethate Sodium for Injection Market - Global Forecast 2026-2032- Product Image
Colistimethate Sodium for Injection Market - Global Forecast 2026-2032- Product Image
Sale

Colistimethate Sodium for Injection Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6124265
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Colistimethate Sodium for Injection Market is projected to reach USD 58.89 Million in 2026. It is expected to continue growing at a CAGR of 11.81%, reaching USD 110.43 Million by 2032.

Colistimethate Sodium for Injection: Executive Overview

Colistimethate sodium for injection is an injectable formulation of colistin used primarily when serious infections caused by susceptible multidrug-resistant Gram-negative bacteria leave limited therapeutic options. Its clinical role is shaped by antimicrobial stewardship, renal and neurological safety considerations, susceptibility testing, hospital formulary controls, and the availability of alternative agents. Use is concentrated in acute-care settings and requires protocol-driven dosing, monitoring, and infection-control support.

Resistance, Stewardship, and Supply Reshape Clinical Use

The landscape is being transformed by the continuing need to manage difficult-to-treat Gram-negative infections while limiting avoidable exposure to polymyxins. Clinical practice is moving toward susceptibility-guided selection, more consistent renal-function assessment, therapeutic monitoring where locally appropriate, and multidisciplinary oversight involving infectious-disease, pharmacy, microbiology, and intensive-care teams. Regulatory scrutiny, medicine-quality assurance, hospital procurement resilience, and infection-prevention programs are also increasingly important because inconsistent supply or inappropriate use can affect both individual patients and resistance-control objectives.

Artificial Intelligence Strengthens Diagnosis and Antimicrobial Governance

Artificial intelligence can support this field by accelerating review of microbiology results, identifying patients at risk of resistant infections, and helping clinicians reconcile renal function, concomitant medicines, and dosing protocols. Predictive tools may improve antimicrobial-stewardship prioritization and detect unusual resistance patterns across hospital networks. These applications remain dependent on representative datasets, transparent validation, cybersecurity, clinician oversight, and careful management of false alerts; AI should augment rather than replace susceptibility testing, expert judgment, and established prescribing safeguards.

Regional Differences Reflect Resistance Burden and Health-System Capacity

In North America and Europe, use is strongly influenced by stewardship standards, laboratory capacity, regulated procurement, and access to newer therapies. Asia-Pacific combines substantial hospital demand with wide variation in resistance surveillance, diagnostic infrastructure, and medicine access across Australia, China, India, Japan, and South Korea. Latin America faces uneven laboratory coverage, procurement conditions, and antimicrobial-governance capacity, with Brazil and Mexico representing important but distinct health-system contexts. In the Middle East, GCC members generally have comparatively organized tertiary-care capacity, while practices vary across the broader region. Africa continues to require stronger microbiology access, reliable supply, infection prevention, and locally adapted stewardship programs.

Multilateral Groups Highlight Divergent Policy and Access Priorities

ASEAN members face differing levels of laboratory readiness, hospital financing, and antimicrobial-resistance surveillance, making regional coordination valuable. BRICS countries encompass large and diverse health systems where manufacturing resilience, access, and stewardship must be addressed together. European Union members benefit from coordinated policy frameworks while retaining national differences in reimbursement, procurement, and clinical protocols. G7 systems generally have mature safety and stewardship infrastructure but still confront resistant infections and supply-chain vulnerabilities. GCC countries can leverage centralized purchasing and advanced tertiary care, while NATO members illustrate the importance of preparedness, cross-border surveillance, and resilient medical supply chains.

Country Contexts Determine Protocols, Access, and Surveillance

Australia, Canada, France, Germany, Italy, Japan, South Korea, Spain, the United Kingdom, and the United States generally operate within established hospital stewardship and pharmacovigilance systems, although formularies, reimbursement, susceptibility practices, and procurement arrangements differ. Brazil, China, India, Mexico, and Russia span highly varied regional access, laboratory capacity, manufacturing environments, and resistance-surveillance coverage. Across all listed countries, responsible use depends on validated products, clear prescribing guidance, renal and neurological monitoring, microbiology support, and timely reporting of adverse events and resistance trends.

Prioritize Safe, Targeted Use and Resilient Availability

Industry leaders should align product quality, regulatory compliance, and dependable supply with stewardship objectives rather than volume-driven use. Practical priorities include supporting standardized dosing and monitoring protocols, strengthening compatibility and administration guidance, investing in diagnostic and susceptibility capabilities, and collaborating with hospitals on education for high-risk patients. Supply planning should diversify critical inputs, qualify backup manufacturing and logistics routes, and maintain transparent shortage communication. Data partnerships can improve pharmacovigilance and resistance surveillance, provided they protect patient privacy and preserve independent clinical decision-making.

Evidence-Based Methodology for the Executive Summary

This summary uses the defined market scope of colistimethate sodium for injection and synthesizes established clinical, regulatory, antimicrobial-stewardship, resistance-surveillance, and health-system considerations. The geographic discussion covers North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, alongside the specified ASEAN, BRICS, European Union, G7, GCC, and NATO groupings and named countries. It intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific analysis. Interpretations should be checked against current national labels, treatment guidelines, susceptibility standards, procurement rules, and local epidemiological evidence.

Responsible Integration Supports Continued Clinical Value

Colistimethate sodium for injection remains a specialized option whose value depends on accurate diagnosis, susceptibility-informed prescribing, careful toxicity management, and disciplined stewardship. Regional and country differences make locally validated protocols essential, while shared surveillance and supply-chain practices can improve resilience. The strongest path forward combines dependable quality, modern diagnostics, responsible data use, clinician oversight, and coordinated infection prevention so that this therapy is preserved for patients who genuinely need it.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Colistimethate Sodium for Injection Market, by Indication
7.1. Introduction
7.2. Bloodstream Infection
7.2.1. Primary Bacteremia
7.2.2. Secondary Bacteremia
7.3. Lower Respiratory Tract Infection
7.3.1. Community Acquired Pneumonia
7.3.2. Hospital Acquired Pneumonia
7.3.3. Ventilator Associated Pneumonia
7.4. Skin And Soft Tissue Infection
7.4.1. Cellulitis
7.4.2. Surgical Site Infection
7.4.3. Wound Infection
7.5. Urinary Tract Infection
7.5.1. Complicated Urinary Tract Infection
7.5.2. Uncomplicated Urinary Tract Infection
8. Colistimethate Sodium for Injection Market, by Dosage Form
8.1. Introduction
8.2. Lyophilized Powder
8.2.1. Multi Dose Vial
8.2.2. Single Dose Vial
8.3. Ready To Use Solution
8.3.1. Infusion Bag
8.3.2. Prefilled Syringe
9. Colistimethate Sodium for Injection Market, by Patient Population
9.1. Introduction
9.2. Adult
9.3. Geriatric
9.4. Pediatric
9.4.1. Adolescent
9.4.2. Child
9.4.3. Infant
9.4.4. Neonatal
10. Colistimethate Sodium for Injection Market, by Route Of Administration
10.1. Introduction
10.2. Inhalation
10.3. Intramuscular
10.4. Intravenous
10.4.1. Continuous Infusion
10.4.2. Intermittent Infusion
11. Colistimethate Sodium for Injection Market, by End User
11.1. Introduction
11.2. Ambulatory Care Center
11.3. Clinic
11.3.1. Outpatient Clinic
11.3.2. Specialty Clinic
11.4. Hospital
11.4.1. General Ward
11.4.2. Intensive Care Unit
12. Colistimethate Sodium for Injection Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Colistimethate Sodium for Injection Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Colistimethate Sodium for Injection Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott
16.2. Fresenius Kabi AG
16.3. Gland Pharma Limited
16.4. Hikma Pharmaceuticals PLC
16.5. Lupin Limited
16.6. Pfizer Inc.
16.7. Sagent Pharmaceuticals, Inc.
16.8. Sandoz International GmbH
16.9. Teva Pharmaceutical Industries Ltd.
16.10. Viatris Inc.
16.11. Zydus Lifesciences Limited
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Colistimethate Sodium for Injection Market, Years Considered for the Study
FIGURE 2. Global Colistimethate Sodium for Injection Market, Research Design
FIGURE 3. Global Colistimethate Sodium for Injection Market, Research Framework
FIGURE 4. Global Colistimethate Sodium for Injection Market, Data Triangulation
FIGURE 5. Global Colistimethate Sodium for Injection Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Colistimethate Sodium for Injection Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 7. Global Colistimethate Sodium for Injection Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Colistimethate Sodium for Injection Market Size, by Dosage Form, 2025 vs 2032 (%)
FIGURE 9. Global Colistimethate Sodium for Injection Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Colistimethate Sodium for Injection Market Size, by Patient Population, 2025 vs 2032 (%)
FIGURE 11. Global Colistimethate Sodium for Injection Market Size, by Patient Population, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Colistimethate Sodium for Injection Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 13. Global Colistimethate Sodium for Injection Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Colistimethate Sodium for Injection Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Colistimethate Sodium for Injection Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Colistimethate Sodium for Injection Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Colistimethate Sodium for Injection Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Colistimethate Sodium for Injection Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Colistimethate Sodium for Injection Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Colistimethate Sodium for Injection Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Colistimethate Sodium for Injection Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Colistimethate Sodium for Injection Market Segmentation & Coverage
TABLE 2. Global Colistimethate Sodium for Injection Market Size, 2017-2032 (USD Million)
TABLE 3. Global Colistimethate Sodium for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 4. Global Bloodstream Infection Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Bloodstream Infection Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Bloodstream Infection Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Primary Bacteremia Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Primary Bacteremia Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Primary Bacteremia Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Secondary Bacteremia Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Secondary Bacteremia Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Secondary Bacteremia Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Lower Respiratory Tract Infection Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Lower Respiratory Tract Infection Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Lower Respiratory Tract Infection Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Community Acquired Pneumonia Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Community Acquired Pneumonia Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Community Acquired Pneumonia Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Hospital Acquired Pneumonia Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Hospital Acquired Pneumonia Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Hospital Acquired Pneumonia Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Ventilator Associated Pneumonia Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Ventilator Associated Pneumonia Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Ventilator Associated Pneumonia Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Skin And Soft Tissue Infection Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Skin And Soft Tissue Infection Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Skin And Soft Tissue Infection Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Cellulitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Cellulitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Cellulitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Surgical Site Infection Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Surgical Site Infection Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Surgical Site Infection Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Wound Infection Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Wound Infection Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Wound Infection Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Urinary Tract Infection Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Urinary Tract Infection Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Urinary Tract Infection Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Complicated Urinary Tract Infection Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Complicated Urinary Tract Infection Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Complicated Urinary Tract Infection Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Uncomplicated Urinary Tract Infection Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Uncomplicated Urinary Tract Infection Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Uncomplicated Urinary Tract Infection Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Colistimethate Sodium for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 47. Global Lyophilized Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Lyophilized Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Lyophilized Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Multi Dose Vial Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Multi Dose Vial Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Multi Dose Vial Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Single Dose Vial Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Single Dose Vial Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Single Dose Vial Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Ready To Use Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Ready To Use Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Ready To Use Solution Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Infusion Bag Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Infusion Bag Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Infusion Bag Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Prefilled Syringe Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Prefilled Syringe Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Prefilled Syringe Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Colistimethate Sodium for Injection Market Size, by Patient Population, 2017-2032 (USD Million)
TABLE 66. Global Adult Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Adult Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Adult Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Geriatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Geriatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Geriatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Adolescent Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Adolescent Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Adolescent Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Child Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Child Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Child Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Infant Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Infant Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Infant Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Neonatal Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Neonatal Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Neonatal Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Colistimethate Sodium for Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 88. Global Inhalation Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Inhalation Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Inhalation Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Continuous Infusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Continuous Infusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Continuous Infusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Intermittent Infusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Intermittent Infusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Intermittent Infusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Colistimethate Sodium for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. Global Ambulatory Care Center Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Ambulatory Care Center Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Ambulatory Care Center Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Outpatient Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Outpatient Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Outpatient Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Specialty Clinic Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Specialty Clinic Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Specialty Clinic Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Hospital Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Hospital Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Hospital Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global General Ward Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global General Ward Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global General Ward Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Intensive Care Unit Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Intensive Care Unit Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Intensive Care Unit Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Colistimethate Sodium for Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Colistimethate Sodium for Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Colistimethate Sodium for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Colistimethate Sodium for Injection Market Size, by Bloodstream Infection, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Colistimethate Sodium for Injection Market Size, by Lower Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Colistimethate Sodium for Injection Market Size, by Skin And Soft Tissue Infection, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Colistimethate Sodium for Injection Market Size, by Urinary Tract Infection, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Colistimethate Sodium for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific Colistimethate Sodium for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific Colistimethate Sodium for Injection Market Size, by Ready To Use Solution, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific Colistimethate Sodium for Injection Market Size, by Patient Population, 2017-2032 (USD Million)
TABLE 136. Asia-Pacific Colistimethate Sodium for Injection Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 137. Asia-Pacific Colistimethate Sodium for Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 138. Asia-Pacific Colistimethate Sodium for Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 139. Asia-Pacific Colistimethate Sodium for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. Asia-Pacific Colistimethate Sodium for Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 141. Asia-Pacific Colistimethate Sodium for Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 142. North America Colistimethate Sodium for Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. North America Colistimethate Sodium for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 144. North America Colistimethate Sodium for Injection Market Size, by Bloodstream Infection, 2017-2032 (USD Million)
TABLE 145. North America Colistimethate Sodium for Injection Market Size, by Lower Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 146. North America Colistimethate Sodium for Injection Market Size, by Skin And Soft Tissue Infection, 2017-2032 (USD Million)
TABLE 147. North America Colistimethate Sodium for Injection Market Size, by Urinary Tract Infection, 2017-2032 (USD Million)
TABLE 148. North America Colistimethate Sodium for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 149. North America Colistimethate Sodium for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 150. North America Colistimethate Sodium for Injection Market Size, by Ready To Use Solution, 2017-2032 (USD Million)
TABLE 151. North America Colistimethate Sodium for Injection Market Size, by Patient Population, 2017-2032 (USD Million)
TABLE 152. North America Colistimethate Sodium for Injection Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 153. North America Colistimethate Sodium for Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 154. North America Colistimethate Sodium for Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 155. North America Colistimethate Sodium for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. North America Colistimethate Sodium for Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 157. North America Colistimethate Sodium for Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 158. Latin America Colistimethate Sodium for Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 159. Latin America Colistimethate Sodium for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 160. Latin America Colistimethate Sodium for Injection Market Size, by Bloodstream Infection, 2017-2032 (USD Million)
TABLE 161. Latin America Colistimethate Sodium for Injection Market Size, by Lower Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 162. Latin America Colistimethate Sodium for Injection Market Size, by Skin And Soft Tissue Infection, 2017-2032 (USD Million)
TABLE 163. Latin America Colistimethate Sodium for Injection Market Size, by Urinary Tract Infection, 2017-2032 (USD Million)
TABLE 164. Latin America Colistimethate Sodium for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 165. Latin America Colistimethate Sodium for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 166. Latin America Colistimethate Sodium for Injection Market Size, by Ready To Use Solution, 2017-2032 (USD Million)
TABLE 167. Latin America Colistimethate Sodium for Injection Market Size, by Patient Population, 2017-2032 (USD Million)
TABLE 168. Latin America Colistimethate Sodium for Injection Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 169. Latin America Colistimethate Sodium for Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 170. Latin America Colistimethate Sodium for Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 171. Latin America Colistimethate Sodium for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. Latin America Colistimethate Sodium for Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 173. Latin America Colistimethate Sodium for Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 174. Europe Colistimethate Sodium for Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 175. Europe Colistimethate Sodium for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 176. Europe Colistimethate Sodium for Injection Market Size, by Bloodstream Infection, 2017-2032 (USD Million)
TABLE 177. Europe Colistimethate Sodium for Injection Market Size, by Lower Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 178. Europe Colistimethate Sodium for Injection Market Size, by Skin And Soft Tissue Infection, 2017-2032 (USD Million)
TABLE 179. Europe Colistimethate Sodium for Injection Market Size, by Urinary Tract Infection, 2017-2032 (USD Million)
TABLE 180. Europe Colistimethate Sodium for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 181. Europe Colistimethate Sodium for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 182. Europe Colistimethate Sodium for Injection Market Size, by Ready To Use Solution, 2017-2032 (USD Million)
TABLE 183. Europe Colistimethate Sodium for Injection Market Size, by Patient Population, 2017-2032 (USD Million)
TABLE 184. Europe Colistimethate Sodium for Injection Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 185. Europe Colistimethate Sodium for Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 186. Europe Colistimethate Sodium for Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 187. Europe Colistimethate Sodium for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. Europe Colistimethate Sodium for Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 189. Europe Colistimethate Sodium for Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 190. Middle East Colistimethate Sodium for Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 191. Middle East Colistimethate Sodium for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 192. Middle East Colistimethate Sodium for Injection Market Size, by Bloodstream Infection, 2017-2032 (USD Million)
TABLE 193. Middle East Colistimethate Sodium for Injection Market Size, by Lower Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 194. Middle East Colistimethate Sodium for Injection Market Size, by Skin And Soft Tissue Infection, 2017-2032 (USD Million)
TABLE 195. Middle East Colistimethate Sodium for Injection Market Size, by Urinary Tract Infection, 2017-2032 (USD Million)
TABLE 196. Middle East Colistimethate Sodium for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 197. Middle East Colistimethate Sodium for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 198. Middle East Colistimethate Sodium for Injection Market Size, by Ready To Use Solution, 2017-2032 (USD Million)
TABLE 199. Middle East Colistimethate Sodium for Injection Market Size, by Patient Population, 2017-2032 (USD Million)
TABLE 200. Middle East Colistimethate Sodium for Injection Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 201. Middle East Colistimethate Sodium for Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 202. Middle East Colistimethate Sodium for Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 203. Middle East Colistimethate Sodium for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. Middle East Colistimethate Sodium for Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 205. Middle East Colistimethate Sodium for Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 206. Africa Colistimethate Sodium for Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 207. Africa Colistimethate Sodium for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 208. Africa Colistimethate Sodium for Injection Market Size, by Bloodstream Infection, 2017-2032 (USD Million)
TABLE 209. Africa Colistimethate Sodium for Injection Market Size, by Lower Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 210. Africa Colistimethate Sodium for Injection Market Size, by Skin And Soft Tissue Infection, 2017-2032 (USD Million)
TABLE 211. Africa Colistimethate Sodium for Injection Market Size, by Urinary Tract Infection, 2017-2032 (USD Million)
TABLE 212. Africa Colistimethate Sodium for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 213. Africa Colistimethate Sodium for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 214. Africa Colistimethate Sodium for Injection Market Size, by Ready To Use Solution, 2017-2032 (USD Million)
TABLE 215. Africa Colistimethate Sodium for Injection Market Size, by Patient Population, 2017-2032 (USD Million)
TABLE 216. Africa Colistimethate Sodium for Injection Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 217. Africa Colistimethate Sodium for Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 218. Africa Colistimethate Sodium for Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 219. Africa Colistimethate Sodium for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. Africa Colistimethate Sodium for Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 221. Africa Colistimethate Sodium for Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 222. Global Colistimethate Sodium for Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 223. ASEAN Colistimethate Sodium for Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 224. ASEAN Colistimethate Sodium for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 225. ASEAN Colistimethate Sodium for Injection Market Size, by Bloodstream Infection, 2017-2032 (USD Million)
TABLE 226. ASEAN Colistimethate Sodium for Injection Market Size, by Lower Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 227. ASEAN Colistimethate Sodium for Injection Market Size, by Skin And Soft Tissue Infection, 2017-2032 (USD Million)
TABLE 228. ASEAN Colistimethate Sodium for Injection Market Size, by Urinary Tract Infection, 2017-2032 (USD Million)
TABLE 229. ASEAN Colistimethate Sodium for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 230. ASEAN Colistimethate Sodium for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 231. ASEAN Colistimethate Sodium for Injection Market Size, by Ready To Use Solution, 2017-2032 (USD Million)
TABLE 232. ASEAN Colistimethate Sodium for Injection Market Size, by Patient Population, 2017-2032 (USD Million)
TABLE 233. ASEAN Colistimethate Sodium for Injection Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 234. ASEAN Colistimethate Sodium for Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 235. ASEAN Colistimethate Sodium for Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 236. ASEAN Colistimethate Sodium for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 237. ASEAN Colistimethate Sodium for Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 238. ASEAN Colistimethate Sodium for Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 239. GCC Colistimethate Sodium for Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 240. GCC Colistimethate Sodium for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 241. GCC Colistimethate Sodium for Injection Market Size, by Bloodstream Infection, 2017-2032 (USD Million)
TABLE 242. GCC Colistimethate Sodium for Injection Market Size, by Lower Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 243. GCC Colistimethate Sodium for Injection Market Size, by Skin And Soft Tissue Infection, 2017-2032 (USD Million)
TABLE 244. GCC Colistimethate Sodium for Injection Market Size, by Urinary Tract Infection, 2017-2032 (USD Million)
TABLE 245. GCC Colistimethate Sodium for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 246. GCC Colistimethate Sodium for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 247. GCC Colistimethate Sodium for Injection Market Size, by Ready To Use Solution, 2017-2032 (USD Million)
TABLE 248. GCC Colistimethate Sodium for Injection Market Size, by Patient Population, 2017-2032 (USD Million)
TABLE 249. GCC Colistimethate Sodium for Injection Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 250. GCC Colistimethate Sodium for Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 251. GCC Colistimethate Sodium for Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 252. GCC Colistimethate Sodium for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 253. GCC Colistimethate Sodium for Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 254. GCC Colistimethate Sodium for Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 255. European Union Colistimethate Sodium for Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 256. European Union Colistimethate Sodium for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 257. European Union Colistimethate Sodium for Injection Market Size, by Bloodstream Infection, 2017-2032 (USD Million)
TABLE 258. European Union Colistimethate Sodium for Injection Market Size, by Lower Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 259. European Union Colistimethate Sodium for Injection Market Size, by Skin And Soft Tissue Infection, 2017-2032 (USD Million)
TABLE 260. European Union Colistimethate Sodium for Injection Market Size, by Urinary Tract Infection, 2017-2032 (USD Million)
TABLE 261. European Union Colistimethate Sodium for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 262. European Union Colistimethate Sodium for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 263. European Union Colistimethate Sodium for Injection Market Size, by Ready To Use Solution, 2017-2032 (USD Million)
TABLE 264. European Union Colistimethate Sodium for Injection Market Size, by Patient Population, 2017-2032 (USD Million)
TABLE 265. European Union Colistimethate Sodium for Injection Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 266. European Union Colistimethate Sodium for Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 267. European Union Colistimethate Sodium for Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 268. European Union Colistimethate Sodium for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. European Union Colistimethate Sodium for Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 270. European Union Colistimethate Sodium for Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 271. BRICS Colistimethate Sodium for Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 272. BRICS Colistimethate Sodium for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 273. BRICS Colistimethate Sodium for Injection Market Size, by Bloodstream Infection, 2017-2032 (USD Million)
TABLE 274. BRICS Colistimethate Sodium for Injection Market Size, by Lower Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 275. BRICS Colistimethate Sodium for Injection Market Size, by Skin And Soft Tissue Infection, 2017-2032 (USD Million)
TABLE 276. BRICS Colistimethate Sodium for Injection Market Size, by Urinary Tract Infection, 2017-2032 (USD Million)
TABLE 277. BRICS Colistimethate Sodium for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 278. BRICS Colistimethate Sodium for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 279. BRICS Colistimethate Sodium for Injection Market Size, by Ready To Use Solution, 2017-2032 (USD Million)
TABLE 280. BRICS Colistimethate Sodium for Injection Market Size, by Patient Population, 2017-2032 (USD Million)
TABLE 281. BRICS Colistimethate Sodium for Injection Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 282. BRICS Colistimethate Sodium for Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 283. BRICS Colistimethate Sodium for Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 284. BRICS Colistimethate Sodium for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 285. BRICS Colistimethate Sodium for Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 286. BRICS Colistimethate Sodium for Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 287. G7 Colistimethate Sodium for Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 288. G7 Colistimethate Sodium for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 289. G7 Colistimethate Sodium for Injection Market Size, by Bloodstream Infection, 2017-2032 (USD Million)
TABLE 290. G7 Colistimethate Sodium for Injection Market Size, by Lower Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 291. G7 Colistimethate Sodium for Injection Market Size, by Skin And Soft Tissue Infection, 2017-2032 (USD Million)
TABLE 292. G7 Colistimethate Sodium for Injection Market Size, by Urinary Tract Infection, 2017-2032 (USD Million)
TABLE 293. G7 Colistimethate Sodium for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 294. G7 Colistimethate Sodium for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 295. G7 Colistimethate Sodium for Injection Market Size, by Ready To Use Solution, 2017-2032 (USD Million)
TABLE 296. G7 Colistimethate Sodium for Injection Market Size, by Patient Population, 2017-2032 (USD Million)
TABLE 297. G7 Colistimethate Sodium for Injection Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 298. G7 Colistimethate Sodium for Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 299. G7 Colistimethate Sodium for Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 300. G7 Colistimethate Sodium for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 301. G7 Colistimethate Sodium for Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 302. G7 Colistimethate Sodium for Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 303. NATO Colistimethate Sodium for Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 304. NATO Colistimethate Sodium for Injection Market Size, by Indication, 2017-2032 (USD Million)
TABLE 305. NATO Colistimethate Sodium for Injection Market Size, by Bloodstream Infection, 2017-2032 (USD Million)
TABLE 306. NATO Colistimethate Sodium for Injection Market Size, by Lower Respiratory Tract Infection, 2017-2032 (USD Million)
TABLE 307. NATO Colistimethate Sodium for Injection Market Size, by Skin And Soft Tissue Infection, 2017-2032 (USD Million)
TABLE 308. NATO Colistimethate Sodium for Injection Market Size, by Urinary Tract Infection, 2017-2032 (USD Million)
TABLE 309. NATO Colistimethate Sodium for Injection Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 310. NATO Colistimethate Sodium for Injection Market Size, by Lyophilized Powder, 2017-2032 (USD Million)
TABLE 311. NATO Colistimethate Sodium for Injection Market Size, by Ready To Use Solution, 2017-2032 (USD Million)
TABLE 312. NATO Colistimethate Sodium for Injection Market Size, by Patient Population, 2017-2032 (USD Million)
TABLE 313. NATO Colistimethate Sodium for Injection Market Size, by Pediatric, 2017-2032 (USD Million)
TABLE 314. NATO Colistimethate Sodium for Injection Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 315. NATO Colistimethate Sodium for Injection Market Size, by Intravenous, 2017-2032 (USD Million)
TABLE 316. NATO Colistimethate Sodium for Injection Market Size, by End User, 2017-2032 (USD Million)
TABLE 317. NATO Colistimethate Sodium for Injection Market Size, by Clinic, 2017-2032 (USD Million)
TABLE 318. NATO Colistimethate Sodium for Injection Market Size, by Hospital, 2017-2032 (USD Million)
TABLE 319. Global Colistimethate Sodium for Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 320. United States Colistimethate Sodium for Injection Market Size, 2017-2032 (USD Million)
TABLE 321. United States C

Companies Mentioned

  • Abbott
  • Fresenius Kabi AG
  • Gland Pharma Limited
  • Hikma Pharmaceuticals PLC
  • Lupin Limited
  • Pfizer Inc.
  • Sagent Pharmaceuticals, Inc.
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Zydus Lifesciences Limited

Related Topics

Related Reports

Micafungin Sodium for Injection Market - Global Forecast 2026-2032 - Product Image

Micafungin Sodium for Injection Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Polyglucose & Sodium Chloride Injection Market - Global Forecast 2026-2032 - Product Image

Polyglucose & Sodium Chloride Injection Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Sodium Hyaluronate Injection for Osteoarthritis Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Sodium Hyaluronate Injection for Osteoarthritis Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 112 Pages
  • Global
From
Metamizole Sodium Injection Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Metamizole Sodium Injection Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 184 Pages
  • Global
From
Lactated Ringer's Injection Market - Global Strategic Business Report - Product Image

Lactated Ringer's Injection Market - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.